Table 2 Summary of single test and NGS performed in the cohort
| Â | Total | Total | Single test vs. NGS | |
|---|---|---|---|---|
Single test | NGS test | Single test | NGS | |
EGFRmutation | n = 75 (%) | N = 100 (%) | n = 75 (%) | |
Mutant | 18 (24) | 23 (23) | 18 (24) | 20 (26.7) |
 Exon 19 deletion | 9 | 10 | 9 | 9 |
 p.L858R | 6 | 6 | 6 | 4 |
 Exon 19 deletion and p.T790M | 2 | 2 | 2 | 2 |
 p.L858R and p.T790M | 1 | 1 | 1 | 1 |
 Uncommon mutations | _ | 4 | _ | 4 |
Wild | 57 (76) | 77 (77) | 57 (76) | 55 (73.3) |
 Concordant cases |  |  | 73 (97.3) | |
 Discordant cases |  |  | 2 (2.7) | |
ALK1 rearrangement | n = 73 (%) | n = 70 (%) | n = 49 (%) | |
 Mutant | 5 (6.8) | 5 (7.1) | 5 (10.2) | 4 (8.2) |
 Wild | 68 (93.2) | 65 (92.9) | 44 (89.8) | 45 (91.8) |
 Concordant cases |  |  | 48 (98) | |
 Discordant cases |  |  | 1 (2) | |
ROS1 fusion | n = 58 (%) | n = 70 (%) | n = 43 (%) | |
 Mutant | 0 (0) | 3 (4.3) | 0 (0) | 1 (2.3) |
 Wild | 58 (58) | 67 (95.7) | 43 (100) | 42 (97.7) |
 Concordant cases |  |  | 42 (97.7) | |
 Discordant cases |  |  | 1 (2.3) | |
c-METamplification | n = 62 (%) | N = 100 (%) | n = 62 (%) | |
 Mutant | 4 (6.5) | 2 (2) | 4 (6.5) | 0 (0) |
 Wild | 58 (93.5) | 98 (98) | 58 (93.5) | 62 (100) |
 Concordant cases |  |  | 58 (93.5) | |
 Discordant cases |  |  | 4 (6.5) | |